First Myeloma CAR T-cell Therapy Phase 2 Trial Opens Enrollment
The U.S. Food and Drug Administration (FDA) has granted…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
FDA Allows Trials of Opdivo Combo Therapy to Resume, Signaling No New Safety Concerns
The U.S. Food and Drug Administration (FDA) agreed to…
Ascentage Gets FDA Nod to Advance APG-1387 into Clinical Trials for Myeloma, Other Cancers
The U.S. Food and Drug Administration (FDA) has…
CAR T-cells Targeting Integrin β7 Protein Show Promise in Countering Multiple Myeloma Cells
A Japanese study has found that an active structure…
First Patient-led Crowdfunding Initiative for Multiple Myeloma Research Tops $500,000 to Fund Two Projects
The first patient-led crowdsourcing and crowdfunding initiative for…
Janssen Seeks US Approval of Darzalex Combo for Newly Diagnosed Multiple Myeloma
Janssen Pharmaceuticals has requested the U.S. Food and…
